Global Image-guided Biopsy Market Research Report 2023

Publication ID:

PB510231735

Publication Date:

October 19, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Image-guided biopsy makes the use of imaging technologies in order to analyze the inside of the body. They utilized MIR, CT, ultrasound and x-ray for this procedure. The biopsy assists the medical professional to get the sample of the suspicious cell easily through the insertion of the needle into the best position. It is considered one of the best ways to collect samples as it causes no unnecessary injuries.
The global Image-guided Biopsy market is projected to reach US$ 1652.7 million in 2029, increasing from US$ 936 million in 2022, with the CAGR of 8.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Image-guided Biopsy 91制片厂.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Image-guided Biopsy market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Koninklijke Philips
Siemens Healthcare
Analogic Corporation
General Electric
Varian Medical Systems
Brainlab
Medtronic
Olympus Corporation
KARL STORZ Endoscopy India
Stryker
Segment by Type
X- Ray
Ultrasound
Mammograpy
CT
MRI
Others
Segment by Application
Hospitals
Ambulatory Surgery Centers
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Image-guided Biopsy report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Image-guided Biopsy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 X- Ray
1.2.3 Ultrasound
1.2.4 Mammograpy
1.2.5 CT
1.2.6 MRI
1.2.7 Others
1.3 Market by Application
1.3.1 Global Image-guided Biopsy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Ambulatory Surgery Centers
1.3.4 Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Image-guided Biopsy Market Perspective (2018-2029)
2.2 Image-guided Biopsy Growth Trends by Region
2.2.1 Global Image-guided Biopsy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Image-guided Biopsy Historic Market Size by Region (2018-2023)
2.2.3 Image-guided Biopsy Forecasted Market Size by Region (2024-2029)
2.3 Image-guided Biopsy Market Dynamics
2.3.1 Image-guided Biopsy Industry Trends
2.3.2 Image-guided Biopsy Market Drivers
2.3.3 Image-guided Biopsy Market Challenges
2.3.4 Image-guided Biopsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Image-guided Biopsy Players by Revenue
3.1.1 Global Top Image-guided Biopsy Players by Revenue (2018-2023)
3.1.2 Global Image-guided Biopsy Revenue Market Share by Players (2018-2023)
3.2 Global Image-guided Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Image-guided Biopsy Revenue
3.4 Global Image-guided Biopsy Market Concentration Ratio
3.4.1 Global Image-guided Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Image-guided Biopsy Revenue in 2022
3.5 Image-guided Biopsy Key Players Head office and Area Served
3.6 Key Players Image-guided Biopsy Product Solution and Service
3.7 Date of Enter into Image-guided Biopsy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Image-guided Biopsy Breakdown Data by Type
4.1 Global Image-guided Biopsy Historic Market Size by Type (2018-2023)
4.2 Global Image-guided Biopsy Forecasted Market Size by Type (2024-2029)
5 Image-guided Biopsy Breakdown Data by Application
5.1 Global Image-guided Biopsy Historic Market Size by Application (2018-2023)
5.2 Global Image-guided Biopsy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Image-guided Biopsy Market Size (2018-2029)
6.2 North America Image-guided Biopsy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Image-guided Biopsy Market Size by Country (2018-2023)
6.4 North America Image-guided Biopsy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Image-guided Biopsy Market Size (2018-2029)
7.2 Europe Image-guided Biopsy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Image-guided Biopsy Market Size by Country (2018-2023)
7.4 Europe Image-guided Biopsy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Image-guided Biopsy Market Size (2018-2029)
8.2 Asia-Pacific Image-guided Biopsy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Image-guided Biopsy Market Size by Region (2018-2023)
8.4 Asia-Pacific Image-guided Biopsy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Image-guided Biopsy Market Size (2018-2029)
9.2 Latin America Image-guided Biopsy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Image-guided Biopsy Market Size by Country (2018-2023)
9.4 Latin America Image-guided Biopsy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Image-guided Biopsy Market Size (2018-2029)
10.2 Middle East & Africa Image-guided Biopsy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Image-guided Biopsy Market Size by Country (2018-2023)
10.4 Middle East & Africa Image-guided Biopsy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Koninklijke Philips
11.1.1 Koninklijke Philips Company Detail
11.1.2 Koninklijke Philips Business Overview
11.1.3 Koninklijke Philips Image-guided Biopsy Introduction
11.1.4 Koninklijke Philips Revenue in Image-guided Biopsy Business (2018-2023)
11.1.5 Koninklijke Philips Recent Development
11.2 Siemens Healthcare
11.2.1 Siemens Healthcare Company Detail
11.2.2 Siemens Healthcare Business Overview
11.2.3 Siemens Healthcare Image-guided Biopsy Introduction
11.2.4 Siemens Healthcare Revenue in Image-guided Biopsy Business (2018-2023)
11.2.5 Siemens Healthcare Recent Development
11.3 Analogic Corporation
11.3.1 Analogic Corporation Company Detail
11.3.2 Analogic Corporation Business Overview
11.3.3 Analogic Corporation Image-guided Biopsy Introduction
11.3.4 Analogic Corporation Revenue in Image-guided Biopsy Business (2018-2023)
11.3.5 Analogic Corporation Recent Development
11.4 General Electric
11.4.1 General Electric Company Detail
11.4.2 General Electric Business Overview
11.4.3 General Electric Image-guided Biopsy Introduction
11.4.4 General Electric Revenue in Image-guided Biopsy Business (2018-2023)
11.4.5 General Electric Recent Development
11.5 Varian Medical Systems
11.5.1 Varian Medical Systems Company Detail
11.5.2 Varian Medical Systems Business Overview
11.5.3 Varian Medical Systems Image-guided Biopsy Introduction
11.5.4 Varian Medical Systems Revenue in Image-guided Biopsy Business (2018-2023)
11.5.5 Varian Medical Systems Recent Development
11.6 Brainlab
11.6.1 Brainlab Company Detail
11.6.2 Brainlab Business Overview
11.6.3 Brainlab Image-guided Biopsy Introduction
11.6.4 Brainlab Revenue in Image-guided Biopsy Business (2018-2023)
11.6.5 Brainlab Recent Development
11.7 Medtronic
11.7.1 Medtronic Company Detail
11.7.2 Medtronic Business Overview
11.7.3 Medtronic Image-guided Biopsy Introduction
11.7.4 Medtronic Revenue in Image-guided Biopsy Business (2018-2023)
11.7.5 Medtronic Recent Development
11.8 Olympus Corporation
11.8.1 Olympus Corporation Company Detail
11.8.2 Olympus Corporation Business Overview
11.8.3 Olympus Corporation Image-guided Biopsy Introduction
11.8.4 Olympus Corporation Revenue in Image-guided Biopsy Business (2018-2023)
11.8.5 Olympus Corporation Recent Development
11.9 KARL STORZ Endoscopy India
11.9.1 KARL STORZ Endoscopy India Company Detail
11.9.2 KARL STORZ Endoscopy India Business Overview
11.9.3 KARL STORZ Endoscopy India Image-guided Biopsy Introduction
11.9.4 KARL STORZ Endoscopy India Revenue in Image-guided Biopsy Business (2018-2023)
11.9.5 KARL STORZ Endoscopy India Recent Development
11.10 Stryker
11.10.1 Stryker Company Detail
11.10.2 Stryker Business Overview
11.10.3 Stryker Image-guided Biopsy Introduction
11.10.4 Stryker Revenue in Image-guided Biopsy Business (2018-2023)
11.10.5 Stryker Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Koninklijke Philips
Siemens Healthcare
Analogic Corporation
General Electric
Varian Medical Systems
Brainlab
Medtronic
Olympus Corporation
KARL STORZ Endoscopy India
Stryker

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.